I sold at $.55 & $.56 and will not be buying until I understand/see the long term strategy for getting SPORT beyond FDA clearance. This may be just a "stop gap" measure. If they are bought beforehand (which I am doubting) so be it.
If I were in charge, before this financing, I would have:
1) Announced through a PR my new chairman of the board,
2) Announced through a PR Fowlers excellent replacement,
3) Announced through a PR the new CEO (again an excellent choice),
4) Announced through a PR a shortened and change in timeline to SPORT CE/FDA clearance.
This would have brought the stock up somewhat, then a financing.
Because of the way this was handled, I believe we have "not much" going on behind the scenes and little options to draw from. Only a hammer in the toolbox, so every problem is a nail....
These are just my own personal opinions.